METTL3 and familial pancreatic carcinoma: METTL3 and METTL14 in the m6A methyltransferase component are expected to become new targets for tumor radiotherapy and chemotherapy sensitization, and METTL3 can promote the chemotherapy and radiotherapy sensitivity of pancreatic cancer cells24.